00 — Prologue

We are decoding a faster kind of immunity.

FUTR bio is a biotechnology company developing next generation mRNA vaccines — single-dose, faster-acting, built to prevent and cure infections and cancer.

01 — Approach

A platform inspired by nature, tuned like an instrument.

Natural UTRs and molecular boosters give our mRNA fine-tuned control over the mammalian immune system — accelerating protection while keeping it regulated and durable.

Molecular illustration of the FUTR bio mRNA vaccine platform
Nature-inspired
Single-dose
Precise
Flexible
Durable
Faster
02 — Pipeline

Drag through the pipeline.

Scroll sideways — four programs, one platform.

FT00P

Next Gen mRNA Vaccine Platform

Co-Development

FT001

COVID-19

FT002

H5N1

FT003

Fluvid (H5N1 + COVID)

03 — People

The people behind the platform.

Drag to meet the team and our scientific board.

André Báfica, MD, PhD

André Báfica, MD, PhD

Scientific Advisor & Co-founder

Daniel Mansur, PhD

Daniel Mansur, PhD

Scientific Advisor & Co-founder

Aline Murad, PhD

Aline Murad, PhD

Scientist — Molecular Biology

Daniel Mendes, PhD

Daniel Mendes, PhD

Scientist — Immunology

Greicy Dias, PhD

Greicy Dias, PhD

Scientist — Molecular Biology

Charles N. Serhan, PhD, DSc

Charles N. Serhan, PhD, DSc

Scientific Advisor

Ruslan Medzhitov, PhD

Ruslan Medzhitov, PhD

Scientific Advisor

04 — Contact

Let’s write the next chapter together.

futr@futr-bio.com
Espaço + Um, Rod. José Carlos Daux, 6977
Santo Antônio de Lisboa, Florianópolis – SC, Brazil